Inflammation and perturbation of the L-carnitine system in heart failure

European Journal of Heart Failure

Volumn 7, Issue 6, 2005, Pages 997-1002

  Vescovo, Giorgio ^a   Ravara, Barbara ^b   Gobbo, Valerio ^b   Libera, Luciano Dalla ^b  

^a SAN BORTOLO HOSPITAL   (Italy)

^b UNIVERSITY OF PADOVA   (Italy)

Author keywords

Heart failure; Inflammation; L carnitine; Sphingosine; TNF

Indexed keywords

CARNITINE; SPHINGOSINE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; FEMALE; HEART FAILURE; HEART VENTRICLE FUNCTION; HUMAN; MALE; MUSCLE ATROPHY; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; CARNITINE; CASE-CONTROL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEART FAILURE, CONGESTIVE; HUMANS; INFLAMMATION MEDIATORS; MALE; MIDDLE AGED; PROBABILITY; PROGNOSIS; REFERENCE VALUES; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; SPHINGOSINE; STROKE VOLUME; TUMOR NECROSIS FACTOR-ALPHA;

EID: 26644466526     PISSN: 13889842     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejheart.2004.11.010     Document Type: Article

References (28)

1. D. Lipkin, D. Jones, J. Round, and P.A. Poole-Wilson Abnormalities of skeletal muscle in patients with chronic heart failure Int. J. Cardiol. 18 1988 187 195
2. D.M. Mancini, N. Reichek, B. Chance, R. Lenkinski, J. Mullen, and J.R. Wilson Contribution of skeletal muscle atrophy to exercise intolerance and altered muscle metabolism in heart failure Circulation 85 1992 1364 1373
3. M. Volterrani, A.L. Clark, P.F. Ludman, J.W. Swan, S. Adamopulos, and M. Piepoli Predictors of exercise capacity in chronic heart failure Eur. Heart J. 15 1994 801 809
4. G. Vescovo, L. Dalla Libera, F. Serafini, C. Leprotti, M. Facchin, and M. Volterrani Improved exercise tolerance after losartan and enalapril in heart failure: correlation with changes in skeletal muscle myosin heavy chain composition Circulation 98 1998 1742 1749
5. G. Vescovo, M. Volterrani, R. Zennaro, M. Sandri, C. Ceconi, and R. Lorusso Apoptosis in the skeletal muscle of patients with heart failure: investigation of clinical and biochemical changes Heart 84 2000 431 437
6. G. Vescovo, F. Serafini, L. Facchin, P. Tenderini, U. Carraro, and L. Dalla Libera Specific changes in skeletal muscle myosin heavy chain composition in cardiac failure: differences compared with disuse atrophy as assessed on microbiopsies by high resolution electrophoresis Heart 76 1996 337 343
7. L. Dalla Libera, B. Ravara, M. Volterrani, V. Gobbo, M. Della Barbera, and A. Angelini Beneficial effects of GH/IGF-1 on skeletal muscle atrophy and function in experimental heart failure Am. J. Physiol., Cell Physiol. 286 2004 C139 C144
8. L. Dalla Libera, R. Sabbadini, C. Renken, B. Ravara, M. Sandri, and R. Betto Apoptosis in the skeletal muscle of rats with heart failure is associated with increased serum levels of TNFα and sphingosine J. Mol. Cell. Cardiol. 33 2001 1871 1878
9. D.L. Mann, and M.B. Reid Exercise training and skeletal muscle inflammation in congestive heart failure: feeling better about fatigue J. Am. Coll. Cardiol. 42 2003 869 872
10. Y.P. Ly, and M.B. Reid NF-kappa B mediates the protein loss induced by TNF-alpha in differentiated skeletal muscle myotubes Am. J. Physiol., Regul. Integr. Comp. Physiol. 279 2000 R1165 R1170
11. E. Baixeras, S. Jeay, P.A. Kelly, and M.C. Postel-Vinay The proliferative and antiapoptotic actions of growth hormone and insulin-like growth factor-1 are mediated through distinct signalling pathways in the Pro-B Ba/F3 cell line Endocrinology 142 2001 137 142
12. G. Pallafacchina, E. Calabria, A.L. Serrano, J.M. Kalhoude, and S. Schiaffino A protein kinase B-dependent and rapamycin sensitive pathway controls skeletal muscle growth but not fibre type specification Proc. Natl. Acad. Sci. U. S. A. 99 2002 9213 9218
13. A. Musaro, K.J. McCullagh, F.J. Naya, E.N. Olson, and N. Rosenthal IGF-1 induces skeletal myocyte hypertrophy through calcineurin in association with GATA-2 and NF-Atc1 Nature 400 1999 581 585
14. G. Vescovo, B. Ravara, V. Gobbo, M. Sandri, A. Angelini, and M. Della Barbera l-Carnitine: a potential treatment for blocking apoptosis and preventing skeletal muscle myopathy in heart failure Am. J. Physiol., Cell Physiol. 283 2002 C802 C810
15. S.E. Harding, S.M. Jones, P. O'Gara, F. del Monte, G. Vescovo, and P.A. Poole-Wilson Isolated ventricular myocytes from failing human heart, the relation of age and clinical status of patients to isoproterenol response J. Mol. Cell. Cardiol. 24 1992 549 564
16. A. Longo, G. Bruno, S. Curti, A. Mancinelli, and G. Miotto Determination of l-carnitine, acetyl-l-carnitine and propionyl-l-carnitine in human plasma by high-performance liquid chromatography after pre-column derivatization with 1-aminoanthracene J. Chromatogr., B, Biomed. Sci. Appl. 686 1996 129 139
17. D.L. Mann Recent insights into the role of tumor necrosis factor in the failing heart Heart Fail. Rev. 6 2001 71 80
18. L. Dalla Libera, and G. Vescovo Muscle wastage in chronic heart failure, between apoptosis, catabolism and altered anabolism: a chimaeric view of inflammation? Curr. Opin. Clin. Nutr. Metab. Care 7 2004 435 441
19. S.D. Anker, and M. Rauchhaus Insights into the pathogenesis of congestive heart failure: immune activation and cachexia Curr. Opin. Cardiol. 14 1999 211 216
20. N.J. Espat, E.M. Copeland, and L.L. Moldawer Tumor necrosis factor and cachexia: a current perspective Surg. Oncol. 3 1994 255 262
21. A.J.S. Coats, A.L. Clark, M. Piepoli, M. Volterrani, and P.A. Poole-Wilson Symptoms and quality of life in heart failure. The muscle hypothesis Br. Heart J. 72 1994 36 39
22. N.W. O'Brien, N.M. Gellings, M. Guo, S.B. Barlow, C.C. Glembotski, and R.A. Sabbadini Factor associated with neutral sphingomyelinase activation and its role in cardiac cell death Circ. Res. 92 2003 589 591
23. W. El-Aroussy, A. Rizk, G. Mayhoub, S.A. Aleem, S. El-Tobgy, and M.S. Mokhtar Plasma carnitine levels as a marker of impaired left ventricular functions Mol. Cell. Biochem. 213 2000 37 71
24. F.M. Vaz, and R.J. Wanders Carnitine biosynthesis in mammals Biochem. J. 361 2002 417 429
25. N. Andrieu-Abadie, J.P. Jaffrezou, S. Hatem, G. Laurent, T. Levade, and J.J. Mercadier l-Carnitine prevents doxorubicin-induced apoptosis of cardiac myocytes: role of inhibition of ceramide generation FASEB J. 13 1999 1501 1510
26. G. Peluso, A. Barbarisi, V. Savica, E. Reda, R. Nicolai, and P. Benfatti Carnitine: an osmolyte that plays a metabolic role J. Cell. Biochem. 80 2001 1 10
27. J. Lin, H. Wu, P.T. Tarr, C.Y. Zhang, Z. Wu, and O. Boss Transcriptional co-activator PGC-1α drives the formation of slow-twitch muscle fibres Nature 418 2002 797 800
28. R. Sharma, and S.D. Anker Cytokines apoptosis and cachexia: the potential for TNF antagonism Int. J. Cardiol. 85 2002 161 171